Transthyretin Amyloidosis (ATTR) Market - Rare Disease Treatment...

added blog Health

2026-07-29 07:47:33 -

Transthyretin Amyloidosis (ATTR) Market - Rare Disease Treatment and Amyloid Inhibition

Market Overview The global transthyretin amyloidosis (ATTR) market is experiencing rapid growth driven by disease diagnosis improvement, targeted therapy approval expansion, and rare disease recognition increasing patient identification. The ATTR market is projected to grow at 15-20% CAGR through 2030, fueled by ATTR prevalence estimates exceeding 500,000 patients globally, multiple approved...

0 Comments 0 Shares 117 Views 0 Reviews